Dr Michael J Moore
Major advances in the treatment of coronary artery disease (CAD) over the last three decades have resulted in dramatic improvements in mortality. Despite this, CAD remains a dominant cause of death. The thrombolytic era in Northern Ireland (NI) revolutionised outcomes for ST elevation myocardial infarction (STEMI) 
EVIDENCE BASE FOR THE ROLE OF SINUS SURGERY IN CHRONIC RHINOSINUSITIS GAINS BETTER DEFINITION.

Dr Brendan Hanna
The landmark paper "Evaluation of the Medical and Surgical Treatment of Chronic Rhinosinusitis: A Prospective, Randomized Controlled trial" 1 demonstrated that 3 months of topical corticosteroids combined with saline nasal rinses and oral macrolide antibiotics produced clinical outcomes equivalent to surgical intervention, in all but those patients with nasal polyposis. The authors' concluded that this medical therapy regimen should be deployed as first line in patients with chronic rhinosinusitis. Many clinicians extrapolated these results, forming the opinion medical therapy to be as good as sinus surgery in chronic rhinosinusitis.
Due to the inherent risks of invasive therapy, surgery is usually reserved for patients who have not had a satisfactory response to medical treatment. In this study randomising patients, at presentation, to either surgery or medical therapy diluted the beneficial effects of surgery by including patients who would have had good outcomes from medical management alone. Here underscores the problem with randomising surgical treatments; patient selection is critical for good surgical outcomes but the process of selection is incompatible with randomisation.
The apparent discrepancy between patient treatment in the randomized trial and in the real clinical world has now been addressed 2 . In this non-randomised study patients with an unsatisfactory response to medical therapy were offered either continued medical therapy or surgery, with a cross-over arm from medical to surgical treatment. There were no statistical differences in disease severity between the cohorts. At one year follow-up surgical patients reported significantly more improvement than medically managed patients.
An evidence base is thus developing for the deployment of sinus surgery as an adjunct to medical therapy where initial medical therapy alone fails. 
'WHAT'S THE POINT OF A GP LOCUM?'
Dr Fiona McEvoy
A partner I had worked with for several years asked me this question recently. Having worked as a long term locum in their practice, doing fully booked surgeries, bloods, letters and housecalls, it was clear that the challenges I had (as a locum GP), and volume of work I had done, were not respected or noticed. I was a commodity with no terms and conditions, no boundaries.
At times in the past I had meekly suggested ways in which the workload could be addressed, or ways I could safely net a housecall when I was on my way to another practice, but these attempts where ignored. I was a ghost. This is what is faced daily by GP locums all over Northern Ireland. I know that because the locums I know are friends and colleagues. Initially when the question was asked I was angry and hurt. On reflection I realised that it was important and needed addressed.
Sessional / non practice based GPs make up 40% of the workforce in the UK. 1 They provide cover for doctors when they are on holidays and when they are sick or need to care for loved ones, but they do not have the team or financial support they need when in the same situation. They are isolated and paid less than partner counterparts who received the same The Ulster Medical Journal www.ums.ac.uk training as them. They work in multiple locations, sometime miles apart, on different computer systems and with different colleagues daily. 2 Locum GP's need to start to take professional and personal responsibility for their work, it is a service provided and as such should have set terms and conditions and Professional boundaries.
The work done needs to be respected not demanded, so patient safety can be assured and locums are not left feeling unequal to their partner counterparts.
